HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Self-Care Devices Will Need New UKCA Mark Post-Brexit

Executive Summary

Self-care medical devices sold in Great Britain post-Brexit will require a new UKCA certification mark, which importantly will not be recognized in the EU, EEA or Northern Ireland, requiring manufacturers to navigate two separate regulatory systems. 

You may also be interested in...

UK Industry Preparing Response To ‘Wide Ranging’ Medical Devices Consultation

UK consumer healthcare industry association PAGB is preparing its response to a "wide ranging" consultation on the future of how medical devices are regulated in the country. MHRA says it wants a system that streamlines product approvals while still prioritizing patient safety.

UK Consumer Health Industry ‘Relieved’ By Post-Brexit Deal

UK consumer health industry association PAGB says it is "relieved" a last minute post-Brexit deal has been struck, which will enable its members to continue to supply OTCs to the EU with limited disruption. 

Stepping Back From The Cliff Edge: UK Industry Welcomes Northern Ireland Brexit Extension

Companies supplying into Northern Ireland now have more time to prepare for post-Brexit regulatory changes in areas like batch testing, imports and Falsified Medicines Directive requirements. UK industry association, PAGB, in a joint statement with five other pharmaceutical industry associations, including AESGP, describes it as a step in the right direction, but also warns that there is still much work to do.

Related Content


Latest News



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts